Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell of proximal tubule | 5 studies | 63% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| kidney | 3 studies | 35% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 1324.42 | 226 / 226 | 85% | 43.79 | 346 / 406 |
| kidney | 100% | 10339.76 | 89 / 89 | 82% | 271.86 | 737 / 901 |
| ovary | 99% | 64.01 | 178 / 180 | 0% | 0 | 0 / 430 |
| spleen | 98% | 37.64 | 236 / 241 | 0% | 0 | 0 / 0 |
| uterus | 93% | 16.30 | 158 / 170 | 0% | 0.03 | 2 / 459 |
| prostate | 92% | 12.33 | 225 / 245 | 0% | 0 | 0 / 502 |
| intestine | 86% | 25.05 | 829 / 966 | 2% | 0.32 | 13 / 527 |
| adrenal gland | 88% | 14.36 | 226 / 258 | 0% | 0 | 0 / 230 |
| thymus | 86% | 8.85 | 563 / 653 | 0% | 0 | 0 / 605 |
| bladder | 86% | 7.43 | 18 / 21 | 0% | 0.05 | 2 / 504 |
| lung | 84% | 12.48 | 487 / 578 | 0% | 0.04 | 5 / 1155 |
| brain | 79% | 7.96 | 2096 / 2642 | 0% | 0.01 | 1 / 705 |
| pancreas | 71% | 5.70 | 233 / 328 | 1% | 0.08 | 2 / 178 |
| breast | 71% | 12.39 | 324 / 459 | 0% | 0.03 | 4 / 1118 |
| blood vessel | 70% | 5.63 | 933 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 65% | 4.20 | 232 / 359 | 1% | 0.04 | 2 / 286 |
| esophagus | 53% | 3.62 | 765 / 1445 | 0% | 0 | 0 / 183 |
| adipose | 53% | 3.87 | 634 / 1204 | 0% | 0 | 0 / 0 |
| skin | 48% | 3.25 | 871 / 1809 | 1% | 0.09 | 6 / 472 |
| heart | 41% | 2.56 | 350 / 861 | 0% | 0 | 0 / 0 |
| muscle | 31% | 1.60 | 250 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 16% | 1.31 | 150 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_1990000 | Biological process | amyloid fibril formation |
| GO_0018003 | Biological process | peptidyl-lysine N6-acetylation |
| GO_0006749 | Biological process | glutathione metabolic process |
| GO_0033116 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment membrane |
| GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0008080 | Molecular function | N-acetyltransferase activity |
| GO_0047198 | Molecular function | cysteine-S-conjugate N-acetyltransferase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004468 | Molecular function | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| Gene name | NAT8 |
| Protein name | N-acetyltransferase 8 (EC 2.3.1.-) (Acetyltransferase 2) (ATase2) (Camello-like protein 1) (Cysteinyl-conjugate N-acetyltransferase) (CCNAT) (EC 2.3.1.80) |
| Synonyms | CML1 GLA TSC501 |
| Description | FUNCTION: Acetylates the free alpha-amino group of cysteine S-conjugates to form mercapturic acids . This is the final step in a major route for detoxification of a wide variety of reactive electrophiles which starts with their incorporation into glutathione S-conjugates. The glutathione S-conjugates are then further processed into cysteine S-conjugates and finally mercapturic acids which are water soluble and can be readily excreted in urine or bile. Alternatively, may have a lysine N-acetyltransferase activity catalyzing peptidyl-lysine N6-acetylation of various proteins. Thereby, may regulate apoptosis through the acetylation and the regulation of the expression of PROM1 . May also regulate amyloid beta-peptide secretion through acetylation of BACE1 and the regulation of its expression in neurons . . |
| Accessions | ENST00000707634.1 Q9UHE5 ENST00000272425.4 |